Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GoM on Pharma Policy Meets Industry, Consumer Bodies (India)

This article was originally published in PharmAsia News

Executive Summary

An India Group of Ministers (GoM) is currently hearing arguments from drug-manufactures and consumer advocates regarding the national regulation of drug prices. Currently, the government maintains a list of "essential" pharmaceuticals for which it sets price caps in hopes of ensuring these medications reach the nation's poorer citizens. Representatives for the pharmaceutical industry argued that drugs in India are already far more inexpensive than in surrounding countries. Ranbaxy Chairman and Managing Director Malvinder Mohan Singh pointed out that although India makes up 14 percent of its total sales, it accounts for only 1 percent in terms of value. He contested that even if costs were further limited, the country does not posses the capabilities to ensure drugs reach those in remote areas. Consumer advocates who addressed the committee called for the creation of a government organization, which would be responsible for regulating the pharmaceutical industry, including cost monitoring. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts